The $3M offering at a likely discount near market price will pressure CVKD shares as new shares are issued. Monitor for potential warrant exercises that could add further dilution. The extended cash runway reduces near-term bankruptcy risk but does not eliminate it.
Price Chart
Executive Summary
Cadrenal Therapeutics announced a $3M private placement with H.C. Wainwright, selling 960,000 shares and warrants that could raise an additional $5.8M. The offering dilutes existing shareholders by approximately 33% given the $9M market cap, extending cash runway into Q1 2027 (H2 2027 if warrants exercised). Near-term bearish due to dilution.
Key Financial Metrics
Key Facts
- $3 million upfront from sale of 960,000 shares (or pre-funded warrants) and warrants
- Warrants for up to 960,000 shares each at $3.00 exercise price
- Potential additional $5.8M if all warrants exercised
- Net proceeds extend cash runway into Q1 2027, or H2 2027 if warrants exercised
- Offering priced at $3.125 per unit
- Expected to close July 1, 2026
- H.C. Wainwright as exclusive placement agent
Financial Impact
Up to $8.8M gross proceeds ($3M upfront + up to $5.8M from warrant exercise) representing significant dilution given $9M market cap; initial $3M causes ~33% dilution.
Risk Factors
- Significant dilution to existing shareholders
- Warrant exercise uncertain; if not exercised, cash runway shorter
- Stock price may decline as shares are issued close to market price
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3320268 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | 8-K | $0.9723 | awaiting T+60 | — | $0.9100 (−6.41%) |
Aug 31, 2026 8w ago | 8-K | $1.75 | awaiting T+60 | — | $0.9100 (−48.00%) |
Jul 21, 2026 13w ago | 8-K | $2.17 $0.9970 | ▼ −54.06% | ▼ −58.03% | $0.9100 (−58.06%) |
Jul 21, 2026 13w ago | EFFECT | $2.17 $0.9970 | ▼ −54.06% | ▼ −58.03% | $0.9100 (−58.06%) |
Jul 1, 2026 16w ago | Press Release | $3.60 $1.12 | ▲ +68.89% | ▲ +71.94% | $0.9100 (+74.72%) |
Jun 29, 2026 16w ago | 8-K | $3.34 $1.32 | ▼ −60.48% | ▼ −64.04% | $0.9100 (−72.75%) |
Jun 18, 2026 18w ago | 8-K | $3.50 $1.06 | ▼ −69.71% | ▼ −71.61% | $0.9100 (−74.00%) |
Jun 15, 2026 18w ago | 144 | $3.04 $1.18 | ▲ +61.18% | ▲ +62.18% | $0.9100 (+70.07%) |
May 7, 2026 24w ago | Press Release | $6.02 $1.96 | ▼ −67.44% | ▼ −71.27% | $0.9100 (−84.88%) |
Apr 30, 2026 25w ago | 8-K | $6.67 $2.06 | ▼ −69.12% | ▼ −72.22% | $0.9100 (−86.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers